Header Logo

THOMAS W BURKE

TitleProfessor
InstitutionMD Anderson
DepartmentGynecological Oncology & Reproductive Medicine
Address1155 Pressler St
HOUSTON TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ross M, Henao R, Burke TW, Ko ER, McClain MT, Ginsburg GS, Woods CW, Tsalik EL. A comparison of host response strategies to distinguish bacterial and viral infection. PLoS One. 2021; 16(12):e0261385. PMID: 34905580; PMCID: PMC8670660.
      Citations: 1     Fields:    Translation:HumansCells
    2. Tan J, Anderson DE, Rathore APS, O'Neill A, Mantri CK, Saron WAA, Lee C, Cui CW, Kang AEZ, Foo R, Kalimuddin S, Low JG, Ho L, Tambyah P, Burke TW, Woods CW, Chan KR, John ALS, Karhausen J. Signatures of mast cell activation are associated with severe COVID-19. medRxiv. 2021 Jun 01. PMID: 34100020; PMCID: PMC8183010.
      Citations:    
    3. Nachman KE, Punshon T, Rardin L, Signes-Pastor AJ, Murray CJ, Jackson BP, Guerinot ML, Burke TA, Chen CY, Ahsan H, Argos M, Cottingham KL, Ginsberg GL, Goodale BC, Kurzius-Spencer M, Meharg AA, Miller MD, Nigra AE, Pendergrast CB, Raab A, Reimer K, Scheckel KG, Schwerdtle T, Taylor VF, Tokar EJ, Warczak TM, Karagas MR, Cubadda F. Opportunities and Challenges for Dietary Arsenic Intervention. Environ Health Perspect. 2018 08; 126(8):84503. PMID: 30235424; PMCID: PMC6375412.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    4. Birnbaum LS, Burke TA, Jones JJ. Informing 21st-Century Risk Assessments with 21st-Century Science. Environ Health Perspect. 2016 Apr; 124(4):A60-3. PMID: 27035154; PMCID: PMC4829990.
      Citations: 9     Fields:    Translation:HumansAnimalsPHPublic Health
    5. Burke TW, Eifel PJ, Ramirez PT, Euscher EE, Schmeler KM, Callegaro-Filho D. Radiotherapy for recurrent small cell carcinoma of the ovary: A case report and review of the literature. Gynecol Oncol Rep. 2015 Jan; 11:23-5. PMID: 26076089; PMCID: PMC4434155.
      Citations: 8     
    6. Lee LJ, Ratner E, Uduman M, Winter K, Boeke M, Greven KM, King S, Burke TW, Underhill K, Kim H, Boulware RJ, Yu H, Parkash V, Lu L, Gaffney D, Dicker AP, Weidhaas J. The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905. PLoS One. 2014; 9(4):e94167. PMID: 24732316; PMCID: PMC3986055.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    7. Walters RS, Albright HW, Weber RS, Feeley TW, Hanna EY, Cantor SB, Lewis CM, Burke TW. Developing a system to track meaningful outcome measures in head and neck cancer treatment. Head Neck. 2014 Feb; 36(2):226-30. PMID: 23729280.
      Citations: 4     Fields:    Translation:Humans
    8. Simeone WJ, Bingham J, Burke TW, Pisters PW. Quality assessment across a national cancer network. J Oncol Pract. 2013 May; 9(3):165-8. PMID: 23942501; PMCID: PMC3651570.
      Citations: 1     Fields:    Translation:Humans
    9. Jhingran A, Ramondetta LM, Bodurka DC, Slomovitz BM, Brown J, Levy LB, Garcia ME, Eifel PJ, Lu KH, Burke TW. A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol. 2013 May; 129(2):304-9. PMID: 23385150; PMCID: PMC4810787.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    10. Ross W, Lynch P, Raju G, Rodriguez A, Burke T, Hafemeister L, Hawk E, Wu X, Dubois RN, Mishra L. Biomarkers, bundled payments, and colorectal cancer care. Genes Cancer. 2012 Jan; 3(1):16-22. PMID: 22893787; PMCID: PMC3415669.
      Citations: 4     
    11. Spinks T, Albright HW, Feeley TW, Walters R, Burke TW, Aloia T, Bruera E, Buzdar A, Foxhall L, Hui D, Summers B, Rodriguez A, Dubois R, Shine KI. Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer. 2012 May 15; 118(10):2571-82. PMID: 22045610; PMCID: PMC3272132.
      Citations: 23     Fields:    Translation:Humans
    12. Lacour RA, Euscher E, Atkinson EN, Sun CC, Ramirez PT, Coleman RL, Brown J, Gano JB, Burke TW, Ramondetta LM. A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma. Int J Gynecol Cancer. 2011 Apr; 21(3):517-22. PMID: 21436700.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    13. Spinks TE, Walters R, Feeley TW, Albright HW, Jordan VS, Bingham J, Burke TW. Improving cancer care through public reporting of meaningful quality measures. Health Aff (Millwood). 2011 Apr; 30(4):664-72. PMID: 21471487.
      Citations: 13     Fields:    
    14. Albright HW, Moreno M, Feeley TW, Walters R, Samuels M, Pereira A, Burke TW. The implications of the 2010 Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act on cancer care delivery. Cancer. 2011 Apr 15; 117(8):1564-74. PMID: 21472704.
      Citations: 22     Fields:    Translation:Humans
    15. Feeley TW, Fly HS, Albright H, Walters R, Burke TW. A method for defining value in healthcare using cancer care as a model. J Healthc Manag. 2010 Nov-Dec; 55(6):399-411; discussion 411-2. PMID: 21166323.
      Citations: 11     Fields:    Translation:Humans
    16. Slomovitz BM, Lu KH, Johnston T, Coleman RL, Munsell M, Broaddus RR, Walker C, Ramondetta LM, Burke TW, Gershenson DM, Wolf J. A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma. Cancer. 2010 Dec 01; 116(23):5415-9. PMID: 20681032; PMCID: PMC5120730.
      Citations: 81     Fields:    Translation:HumansCTClinical Trials
    17. Rutkow L, Levin MB, Burke TA. Meeting local needs while developing public health practice skills: a model community-academic partnership. J Public Health Manag Pract. 2009 Sep-Oct; 15(5):425-31. PMID: 19704311.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    18. Ramondetta LM, Johnson AJ, Sun CC, Atkinson N, Smith JA, Jung MS, Broaddus R, Iyer RB, Burke T. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer. 2009 May 01; 115(9):1867-74. PMID: 19241422.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    19. Burke T, Chalas E. New membership model. Gynecol Oncol. 2009 Jan; 112(1):4-5. PMID: 19100915.
      Citations:    Fields:    Translation:Humans
    20. Burke TW. The origins of multidisciplinary cancer care. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S2-3. PMID: 18785320.
      Citations: 2     Fields:    Translation:Humans
    21. Lu KH, Wu W, Dave B, Slomovitz BM, Burke TW, Munsell MF, Broaddus RR, Walker CL. Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Clin Cancer Res. 2008 May 01; 14(9):2543-50. PMID: 18451215.
      Citations: 29     Fields:    Translation:HumansCells
    22. Navo MA, Smith JA, Gaikwad A, Burke T, Brown J, Ramondetta LM. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines. Cancer Chemother Pharmacol. 2008 Aug; 62(3):483-9. PMID: 18004570.
      Citations: 8     Fields:    Translation:HumansCells
    23. Frumovitz M, Bodurka DC, Broaddus RR, Coleman RL, Sood AK, Gershenson DM, Burke TW, Levenback CF. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol. 2007 Jan; 104(1):100-3. PMID: 16963111.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    24. Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol. 2006 Oct; 103(1):155-9. PMID: 16545437.
      Citations: 57     Fields:    Translation:HumansCTClinical Trials
    25. Coleman RL, Broaddus RR, Bodurka DC, Wolf JK, Burke TW, Kavanagh JJ, Levenback CF, Gershenson DM. Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers. Gynecol Oncol. 2006 Apr; 101(1):126-31. PMID: 16271384.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    26. Straughn JM, Numnum TM, Kilgore LC, Partridge EE, Phillips JL, Markman M, Thomas GM, Burke TW, Gynecologic Oncology Disease Site Team. The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data Base. Gynecol Oncol. 2005 Dec; 99(3):530-5. PMID: 16198401.
      Citations:    Fields:    Translation:Humans
    27. Rubatt JM, Slomovitz BM, Burke TW, Broaddus RR. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia. Gynecol Oncol. 2005 Nov; 99(2):472-6. PMID: 16099019.
      Citations: 3     Fields:    Translation:Humans
    28. Lee CM, Slomovitz BM, Greer M, Sharma S, Gregurich MA, Burke T, Lu KH, Ramondetta LM. Practice patterns of SGO members for stage IIIA endometrial cancer. Gynecol Oncol. 2005 Jul; 98(1):77-83. PMID: 15907988.
      Citations: 6     Fields:    Translation:Humans
    29. Brown J, Shvartsman HS, Deavers MT, Ramondetta LM, Burke TW, Munsell MF, Gershenson DM. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol. 2005 May; 97(2):489-96. PMID: 15863149.
      Citations: 25     Fields:    Translation:Humans
    30. Slomovitz BM, Ramondetta LM, Lee CM, Oh JC, Eifel PJ, Jhingran A, Burke TW, Gershenson DM, Lu KH. Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. Int J Gynecol Cancer. 2005 May-Jun; 15(3):510-6. PMID: 15882178.
      Citations: 3     Fields:    Translation:Humans
    31. Arredondo A, Burke TA, Carides GW, Lemus E, Querol J. The impact of losartan on the lifetime incidence of ESRD and costs in Mexico. Rev Invest Clin. 2005 May-Jun; 57(3):399-405. PMID: 16187699.
      Citations: 2     Fields:    Translation:Humans
    32. Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005 Mar; 105(3):575-80. PMID: 15738027.
      Citations: 66     Fields:    Translation:Humans
    33. See HT, Freedman RS, Kudelka AP, Burke TW, Gershenson DM, Tangjitgamol S, Kavanagh JJ. Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance. Int J Gynecol Cancer. 2005 Mar-Apr; 15(2):209-16. PMID: 15823101.
      Citations: 15     Fields:    Translation:Humans
    34. Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S, Bandipalliam P, Chen LM, Allen B, Conrad P, Terdiman J, Sun C, Daniels M, Burke T, Gershenson DM, Lynch H, Lynch P, Broaddus RR. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005 Mar; 105(3):569-74. PMID: 15738026.
      Citations: 84     Fields:    Translation:Humans
    35. Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH. Expression of imatinib mesylate-targeted kinases in endometrial carcinoma. Gynecol Oncol. 2004 Oct; 95(1):32-6. PMID: 15385107.
      Citations: 9     Fields:    Translation:HumansCells
    36. Brown J, Shvartsman HS, Deavers MT, Burke TW, Munsell MF, Gershenson DM. The activity of taxanes in the treatment of sex cord-stromal ovarian tumors. J Clin Oncol. 2004 Sep 01; 22(17):3517-23. PMID: 15337800.
      Citations: 14     Fields:    Translation:Humans
    37. Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH. Her-2/neu overexpression and amplification in uterine papillary serous carcinoma. J Clin Oncol. 2004 Aug 01; 22(15):3126-32. PMID: 15284264.
      Citations: 59     Fields:    Translation:Humans
    38. Donato ML, Aleman A, Champlin RE, Saliba RM, Wharton JT, Burke TW, Bodurka DC, Bevers MW, Levenback CF, Wolf JK, Bast RC, Freedman RS, Ippoliti C, Brewer M, Gajewski JL, Gershenson DM. Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant. 2004 Jun; 33(12):1219-24. PMID: 15122311.
      Citations: 5     Fields:    Translation:Humans
    39. Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T, Radiation Therapy Oncology Group. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):168-73. PMID: 15093913.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    40. Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2004 May; 13(5):748-52. PMID: 15159305.
      Citations: 13     Fields:    Translation:Humans
    41. Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ. Malignant mixed M?llerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys. 2004 Mar 01; 58(3):786-96. PMID: 14967435.
      Citations: 58     Fields:    Translation:HumansPHPublic Health
    42. Frumovitz M, Ramirez PT, Tortolero-Luna G, Malpica A, Eifel P, Burke TW, Levenback C. Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol. 2004 Jan; 92(1):205-10. PMID: 14751159.
      Citations: 5     Fields:    Translation:Humans
    43. Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol. 2003 Dec; 91(3):463-9. PMID: 14675663.
      Citations: 73     Fields:    Translation:Humans
    44. Ramondetta LM, Burke TW, Jhingran A, Schmandt R, Bevers MW, Wolf JK, Levenback CF, Broaddus R. A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed m?llerian tumors with evaluation of potential molecular targets. Gynecol Oncol. 2003 Sep; 90(3):529-36. PMID: 13678720.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    45. Gordinier ME, Malpica A, Burke TW, Bodurka DC, Wolf JK, Jhingran A, Ramirez PT, Levenback C. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003 Sep; 90(3):625-8. PMID: 13678736.
      Citations: 8     Fields:    Translation:Humans
    46. Burke TW, Walker CL. Arzoxifene as therapy for endometrial cancer. Gynecol Oncol. 2003 Aug; 90(2 Pt 2):S40-6. PMID: 12928005.
      Citations: 7     Fields:    Translation:Humans
    47. Jhingran A, Burke TW, Eifel PJ. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys. 2003 Aug 01; 56(5):1366-72. PMID: 12873682.
      Citations: 27     Fields:    Translation:Humans
    48. Brown J, Broaddus R, Koeller M, Burke TW, Gershenson DM, Bodurka DC. Sarcomatoid carcinoma of the cervix. Gynecol Oncol. 2003 Jul; 90(1):23-8. PMID: 12821337.
      Citations: 10     Fields:    Translation:Humans
    49. McMeekin DS, Gordon A, Fowler J, Melemed A, Buller R, Burke T, Bloss J, Sabbatini P. A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer. Gynecol Oncol. 2003 Jul; 90(1):64-9. PMID: 12821343.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    50. Kabbani W, Deavers MT, Malpica A, Burke TW, Liu J, Jhingran A, Silva EG, Ordo?ez NG. Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma. Int J Gynecol Pathol. 2003 Jul; 22(3):297-302. PMID: 12819400.
      Citations: 12     Fields:    Translation:HumansCells
    51. Litt JS, Burke TA. Uncovering the historic environmental hazards of urban brownfields. J Urban Health. 2002 Dec; 79(4):464-81. PMID: 12468667; PMCID: PMC3456720.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    52. Munkarah AR, Jhingran A, Iyer RB, Wallace S, Eifel PJ, Gershenson D, Burke TW. Utility of lymphangiography in the prediction of lymph node metastases in patients with cervical cancer. Int J Gynecol Cancer. 2002 Nov-Dec; 12(6):755-9. PMID: 12445255.
      Citations: 1     Fields:    Translation:Humans
    53. Holtz D, Ramondetta LM, Burke TW, Palazzo JP, Dunton CJ, Atkinson EN, Broaddus RR. PTEN expression in tamoxifen-associated endometrial cancers. Anticancer Res. 2002 Sep-Oct; 22(5):2945-8. PMID: 12530022.
      Citations: 2     Fields:    Translation:Humans
    54. Ramondetta LM, Silva EG, Levenback CF, Burke TW. Mixed choriocarcinoma in a postmenopausal patient. Int J Gynecol Cancer. 2002 May-Jun; 12(3):312-6. PMID: 12060455.
      Citations: 9     Fields:    Translation:HumansCells
    55. Litt JS, Tran NL, Burke TA. Examining urban brownfields through the public health "macroscope". Environ Health Perspect. 2002 Apr; 110 Suppl 2:183-93. PMID: 11929727; PMCID: PMC1241162.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    56. Levenback C, Coleman RL, Burke TW, Lin WM, Erdman W, Deavers M, Delpassand ES. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 2002 Feb 01; 20(3):688-93. PMID: 11821449.
      Citations: 40     Fields:    Translation:Humans
    57. Rabeneck L, Wristers K, Goldstein JL, Eisen G, Dedhiya SD, Burke TA. Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy. Am J Gastroenterol. 2002 Jan; 97(1):32-9. PMID: 11808967.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    58. Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 2001 Nov; 83(2):276-81. PMID: 11606084.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    59. Ramirez PT, Ramondetta LM, Burke TW, Gershenson DM, Brewer MA. Metastatic uterine papillary serous carcinoma to the pericardium. Gynecol Oncol. 2001 Oct; 83(1):135-7. PMID: 11585425.
      Citations: 3     Fields:    Translation:Humans
    60. Donato ML, Gershenson DM, Wharton JT, Ippoliti CM, Aleman AS, Bodurka-Bevers D, Bevers MW, Burke TW, Levenback CF, Wolf JK, Freedman RS, Bast RC, Gajewski JL, Champlin RE. High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer. Gynecol Oncol. 2001 Sep; 82(3):420-6. PMID: 11520135.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    61. Ramirez PT, Levenback C, Burke TW, Eifel P, Wolf JK, Gershenson DM. Sigmoid perforation following radiation therapy in patients with cervical cancer. Gynecol Oncol. 2001 Jul; 82(1):150-5. PMID: 11426977.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    62. Ramondetta L, Burke TW, Levenback C, Bevers M, Bodurka-Bevers D, Gershenson DM. Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecol Oncol. 2001 Jul; 82(1):156-61. PMID: 11426978.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    63. Lu KH, Burke TW. Early cervical cancer. Curr Treat Options Oncol. 2000 Jun; 1(2):147-55. PMID: 12057052.
      Citations: 6     Fields:    Translation:Humans
    64. Donato ML, Gershenson D, Ippoliti C, Wharton JT, Bast RC, Aleman A, Anderlini P, Gajewski JG, Giralt S, Molldrem J, Ueno N, Lauppe J, Korbling M, Boyer J, Bodurka-Bevers D, Bevers M, Burke T, Freedman R, Levenback C, Wolf J, Champlin RE. High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant. 2000 Jun; 25(11):1137-40. PMID: 10849525.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    65. Ramondetta L, Mills GB, Burke TW, Wolf JK. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer. Clin Cancer Res. 2000 Jan; 6(1):278-84. PMID: 10656459.
      Citations: 7     Fields:    Translation:HumansCells
    66. Pustilnik T, Burke TW. Adjuvant chemotherapy for high-risk endometrial cancer. Semin Radiat Oncol. 2000 Jan; 10(1):23-8. PMID: 10671655.
      Citations: 3     Fields:    Translation:Humans
    67. Gershenson DM, Morris M, Burke TW, Levenback C, Wolf J, Lee JJ, Thall PF, Atkinson EN, Silva EG, Wharton JT. A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma. Cancer. 1999 Dec 01; 86(11):2291-300. PMID: 10590370.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    68. Wolf JK, Mullen J, Eifel PJ, Burke TW, Levenback C, Gershenson DM. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol. 1999 Apr; 73(1):35-41. PMID: 10094877.
      Citations: 14     Fields:    Translation:Humans
    69. Lin PS, Gershenson DM, Bevers MW, Lucas KR, Burke TW, Silva EG. The current status of surgical staging of ovarian serous borderline tumors. Cancer. 1999 Feb 15; 85(4):905-11. PMID: 10091769.
      Citations: 11     Fields:    Translation:Humans
    70. Gershenson DM, Burke TW, Morris M, Bast RC, Guaspari A, Hohneker J, Wharton JT. A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer. Gynecol Oncol. 1998 Sep; 70(3):404-9. PMID: 9790795.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    71. Ijaz T, Eifel PJ, Burke T, Oswald MJ. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma. Gynecol Oncol. 1998 Aug; 70(2):241-6. PMID: 9740698.
      Citations: 14     Fields:    Translation:Humans
    72. Morris M, Brader KR, Burke TW, Levenback CF, Gershenson DM. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix. Gynecol Oncol. 1998 Aug; 70(2):215-8. PMID: 9740693.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    73. Gershenson DM, Silva EG, Levy L, Burke TW, Wolf JK, Tornos C. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer. 1998 Mar 15; 82(6):1096-103. PMID: 9506355.
      Citations: 19     Fields:    Translation:Humans
    74. Morris M, Brader KR, Levenback C, Burke TW, Atkinson EN, Scott WR, Gershenson DM. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix. J Clin Oncol. 1998 Mar; 16(3):1094-8. PMID: 9508195.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    75. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med. 1997 Aug 15; 127(4):267-74. PMID: 9265425.
      Citations: 96     Fields:    Translation:HumansCTClinical Trials
    76. Burke TW. How should we monitor women treated for endometrial carcinoma? Gynecol Oncol. 1997 Jun; 65(3):377-8. PMID: 9190959.
      Citations:    Fields:    Translation:HumansPHPublic Health
    77. Morris M, Levenback C, Burke TW, Dejesus Y, Lucas KR, Gershenson DM. An outcomes management program in gynecologic oncology. Obstet Gynecol. 1997 Apr; 89(4):485-92. PMID: 9083300.
      Citations: 4     Fields:    Translation:Humans
    78. Munkarah AR, Hallum AV, Morris M, Burke TW, Levenback C, Atkinson EN, Wharton JT, Gershenson DM. Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer. Gynecol Oncol. 1997 Jan; 64(1):13-7. PMID: 8995541.
      Citations: 16     Fields:    Translation:Humans
    79. Ratliff CR, Gershenson DM, Morris M, Burke TW, Levenback C, Schover LR, Mitchell MF, Atkinson EN, Wharton JT. Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer. 1996 Nov 15; 78(10):2229-35. PMID: 8918419.
      Citations: 5     Fields:    Translation:Humans
    80. Levenback C, Burke TW, Rubin SC, Curtin JP, Wharton JT. Arterial occlusion complicating treatment of gynecologic cancer: a case series. Gynecol Oncol. 1996 Oct; 63(1):40-6. PMID: 8898166.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    81. Sutton GP, Blessing JA, DeMars LR, Moore D, Burke TW, Grendys EC. A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium. Gynecol Oncol. 1996 Oct; 63(1):25-7. PMID: 8898163.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    82. Segreti EM, Morris M, Levenback C, Lucas KR, Gershenson DM, Burke TW. Transverse colon urinary diversion in gynecologic oncology. Gynecol Oncol. 1996 Oct; 63(1):66-70. PMID: 8898171.
      Citations: 3     Fields:    Translation:Humans
    83. Burke TW, Gershenson DM. Chemotherapy as adjuvant and salvage treatment in women with endometrial carcinoma. Clin Obstet Gynecol. 1996 Sep; 39(3):716-27. PMID: 8862895.
      Citations: 2     Fields:    Translation:Humans
    84. Sherertz RJ, Heard SO, Raad II, Gentry L, Bowton D, Scuderi P, Hu J, Carruth W, Satishchandra B, Pepe J, Mosenthal A, Burke T, Dupuis J. Gamma radiation-sterilized, triple-lumen catheters coated with a low concentration of chlorhexidine were not efficacious at preventing catheter infections in intensive care unit patients. Antimicrob Agents Chemother. 1996 Sep; 40(9):1995-7. PMID: 8878569; PMCID: PMC163461.
      Citations: 5     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    85. Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol. 1996 Aug; 62(2):169-73. PMID: 8751545.
      Citations: 58     Fields:    Translation:Humans
    86. Wolf JK, Levenback C, Malpica A, Morris M, Burke T, Mitchell MF. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol. 1996 Jul; 88(1):82-6. PMID: 8684768.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    87. Levenback C, Morris M, Burke TW, Gershenson DM, Wolf JK, Wharton JT. Groin dissection practices among gynecologic oncologists treating early vulvar cancer. Gynecol Oncol. 1996 Jul; 62(1):73-7. PMID: 8690296.
      Citations: 5     Fields:    Translation:Humans
    88. Burke TW, Tortolero-Luna G, Malpica A, Baker VV, Whittaker L, Johnson E, Follen Mitchell M. Endometrial hyperplasia and endometrial cancer. Obstet Gynecol Clin North Am. 1996 Jun; 23(2):411-56. PMID: 8784886.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    89. Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996 Apr; 87(4):527-31. PMID: 8602303.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    90. Currie J, Blessing JA, Muss HB, Fowler J, Berman M, Burke TW. Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: a Gynecologic Oncology Group study. Gynecol Oncol. 1996 Apr; 61(1):27-30. PMID: 8626112.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    91. Segreti EM, Levenback C, Morris M, Lucas KR, Gershenson DM, Burke TW. A comparison of end and loop colostomy for fecal diversion in gynecologic patients with colonic fistulas. Gynecol Oncol. 1996 Jan; 60(1):49-53. PMID: 8557227.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    92. Sweeten KM, Gershenson DM, Burke TW, Morris M, Levenback C, Silva EG. Salvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC). Gynecol Oncol. 1995 Nov; 59(2):211-5. PMID: 7590475.
      Citations: 4     Fields:    Translation:Humans
    93. Reddoch JM, Burke TW, Morris M, Tornos C, Levenback C, Gershenson DM. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol Oncol. 1995 Nov; 59(2):221-5. PMID: 7590477.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    94. Levenback C, Burke TW, Morris M, Malpica A, Lucas KR, Gershenson DM. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol. 1995 Nov; 59(2):216-20. PMID: 7590476.
      Citations: 12     Fields:    Translation:Humans
    95. Eifel PJ, Morris M, Burke TW, Levenback C, Gershenson DM. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 1995 Oct; 59(1):51-6. PMID: 7557615.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    96. Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol. 1995 Oct; 59(1):38-44. PMID: 7557613.
      Citations: 59     Fields:    Translation:Humans
    97. Kieback DG, Burke TW. Modified instruments for mobilization of the ureters and parametrial transsection during radical hysterectomy. Ann Surg Oncol. 1995 Sep; 2(5):435-9. PMID: 7496839.
      Citations:    Fields:    Translation:Humans
    98. Gershenson DM, Morris M, Burke TW, Levenback C, Kavanagh JJ, Fromm GL, Silva EG, Warner D, Wharton JT. Combined cisplatin and carboplatin chemotherapy for treatment of advanced epithelial ovarian cancer. Gynecol Oncol. 1995 Sep; 58(3):349-55. PMID: 7672700.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    99. Miller B, Morris M, Levenback C, Burke TW, Gershenson DM. Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol. 1995 Aug; 58(2):202-5. PMID: 7622106.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    100. Chuang L, Burke TW, Tornos C, Marino BD, Mitchell MF, Tortolero-Luna G, Levenback C, Morris M, Gershenson DM. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol. 1995 Aug; 58(2):189-93. PMID: 7622103.
      Citations: 13     Fields:    Translation:Humans
    101. Bicher A, Levenback C, Burke TW, Morris M, Warner D, DeJesus Y, Gershenson DM. Infusion site soft-tissue injury after paclitaxel administration. Cancer. 1995 Jul 01; 76(1):116-20. PMID: 8630862.
      Citations: 4     Fields:    Translation:Humans
    102. Malpica A, Tornos C, Burke TW, Silva EG. Low-stage clear-cell carcinoma of the endometrium. Am J Surg Pathol. 1995 Jul; 19(7):769-74. PMID: 7793474.
      Citations: 6     Fields:    Translation:Humans
    103. Bicher A, Levenback C, Silva EG, Burke TW, Morris M, Gershenson DM. Ovarian malignant mixed m?llerian tumors treated with platinum-based chemotherapy. Obstet Gynecol. 1995 May; 85(5 Pt 1):735-9. PMID: 7724104.
      Citations: 6     Fields:    Translation:Humans
    104. Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson DM. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol. 1995 May; 57(2):215-20. PMID: 7729737.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    105. Gabel C, Eifel PJ, Tornos C, Burke TW. Radiation recall reaction to idarubicin resulting in vaginal necrosis. Gynecol Oncol. 1995 May; 57(2):266-9. PMID: 7729748.
      Citations: 4     Fields:    Translation:Humans
    106. Burke TW, Morris M, Roh MS, Levenback C, Gershenson DM. Perineal reconstruction using single gracilis myocutaneous flaps. Gynecol Oncol. 1995 May; 57(2):221-5. PMID: 7729738.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    107. Morris M, Eifel PJ, Burke TW, McNamara MM, Levenback C, Kavanagh JJ, Gershenson DM. Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynecol Oncol. 1995 Apr; 57(1):72-8. PMID: 7705704.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    108. Miller B, Umpierre S, Tornos C, Burke T. Histologic characterization of uterine papillary serous adenocarcinoma. Gynecol Oncol. 1995 Mar; 56(3):425-9. PMID: 7705679.
      Citations: 1     Fields:    Translation:HumansCells
    109. Miller B, Morris M, Gershenson DM, Levenback CL, Burke TW. Intestinal fistulae formation following pelvic exenteration: a review of the University of Texas M. D. Anderson Cancer Center experience, 1957-1990. Gynecol Oncol. 1995 Feb; 56(2):207-10. PMID: 7896187.
      Citations: 6     Fields:    Translation:Humans
    110. Marino BD, Burke TW, Tornos C, Chuang L, Mitchell MF, Tortolero-Luna G, Morris M, Gershenson DM. Staging laparotomy for endometrial carcinoma: assessment of peritoneal spread. Gynecol Oncol. 1995 Jan; 56(1):34-8. PMID: 7821845.
      Citations: 3     Fields:    Translation:Humans
    111. Burke TW, Fowler WC, Morrow CP. Clinical aspects of risk in women with endometrial carcinoma. J Cell Biochem Suppl. 1995; 23:131-6. PMID: 8747387.
      Citations: 4     Fields:    Translation:Humans
    112. Burke TW, Morris M, Levenback C, Gershenson DM, Wharton JT. Closure of complex vulvar defects using local rhomboid flaps. Obstet Gynecol. 1994 Dec; 84(6):1043-7. PMID: 7970463.
      Citations: 2     Fields:    Translation:Humans
    113. Lehman E, Gershenson DM, Burke TW, Levenback C, Silva EG, Morris M. Salvage surgery for chemorefractory gestational trophoblastic disease. J Clin Oncol. 1994 Dec; 12(12):2737-42. PMID: 7989951.
      Citations: 11     Fields:    Translation:Humans
    114. Levenback C, Eifel PJ, Burke TW, Morris M, Gershenson DM. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994 Nov; 55(2):206-10. PMID: 7959285.
      Citations: 24     Fields:    Translation:HumansPHPublic Health
    115. Munkarah A, Gershenson DM, Levenback C, Silva EG, Messing MJ, Morris M, Burke TW. Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol. 1994 Nov; 55(2):217-23. PMID: 7959287.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    116. Burke TW, Gershenson DM, Morris M, Stringer CA, Levenback C, Tortolero-Luna G, Baker VV. Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. Gynecol Oncol. 1994 Oct; 55(1):47-50. PMID: 7959265.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    117. Coleman RL, Keeney ED, Freedman RS, Burke TW, Eifel PJ, Rutledge FN. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Gynecol Oncol. 1994 Oct; 55(1):29-35. PMID: 7959262.
      Citations: 12     Fields:    Translation:Humans
    118. Levenback C, Burke TW, Gershenson DM, Morris M, Malpica A, Ross MI. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol. 1994 Aug; 84(2):163-7. PMID: 8041523.
      Citations: 30     Fields:    Translation:Humans
    119. Bicher A, Sahin AA, Burke TW. Metastatic cervical cancer presenting as cholecystitis. Gynecol Oncol. 1994 Aug; 54(2):250-3. PMID: 8063256.
      Citations: 1     Fields:    Translation:Humans
    120. Tornos C, Silva EG, Khorana SM, Burke TW. High-stage endometrioid carcinoma of the ovary. Prognostic significance of pure versus mixed histologic types. Am J Surg Pathol. 1994 Jul; 18(7):687-93. PMID: 8017563.
      Citations: 2     Fields:    Translation:Humans
    121. Morris M, Gershenson DM, Burke TW, Mitchell MF, Levenback C, Atkinson N, Wharton JT. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix. Gynecol Oncol. 1994 May; 53(2):234-8. PMID: 8188085.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    122. Umpierre SA, Burke TW, Tornos C, Ordonez N, Levenback C, Morris M. Immunocytochemical analysis of uterine papillary serous carcinomas for estrogen and progesterone receptors. Int J Gynecol Pathol. 1994 Apr; 13(2):127-30. PMID: 8005733.
      Citations: 1     Fields:    Translation:Humans
    123. Levenback C, Gershenson DM, McGehee R, Eifel PJ, Morris M, Burke TW. Enterovesical fistula following radiotherapy for gynecologic cancer. Gynecol Oncol. 1994 Mar; 52(3):296-300. PMID: 8157186.
      Citations: 3     Fields:    Translation:Humans
    124. Burke TW, Morris M. Secondary cytoreductive surgery for ovarian cancer. Obstet Gynecol Clin North Am. 1994 Mar; 21(1):167-78. PMID: 8015762.
      Citations: 10     Fields:    Translation:Humans
    125. Burke TW, Wolfson AH. Limited endometrial carcinoma: adjuvant therapy. Semin Oncol. 1994 Feb; 21(1):84-90. PMID: 8310314.
      Citations:    Fields:    Translation:Humans
    126. Coleman RL, Burke TW, Morris M, Eifel PJ, Hallum AV, Wallace S, Tornos C. Intraoperative radiographs to confirm the adequacy of lymph node resection in patients with suspicious lymphangiograms. Gynecol Oncol. 1993 Dec; 51(3):362-7. PMID: 8112646.
      Citations:    Fields:    Translation:Humans
    127. Burke TW, Munkarah A, Kavanagh JJ, Morris M, Levenback C, Tornos C, Gershenson DM. Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin. Gynecol Oncol. 1993 Dec; 51(3):397-400. PMID: 8112651.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    128. Kupelian PA, Eifel PJ, Tornos C, Burke TW, Delclos L, Oswald MJ. Treatment of endometrial carcinoma with radiation therapy alone. Int J Radiat Oncol Biol Phys. 1993 Nov 15; 27(4):817-24. PMID: 8244810.
      Citations: 8     Fields:    Translation:Humans
    129. Roman LD, Morris M, Mitchell MF, Eifel PJ, Burke TW, Atkinson EN. Prognostic factors for patients undergoing simple hysterectomy in the presence of invasive cancer of the cervix. Gynecol Oncol. 1993 Aug; 50(2):179-84. PMID: 8375732.
      Citations: 3     Fields:    Translation:Humans
    130. Miller B, Morris M, Rutledge F, Mitchell MF, Atkinson EN, Burke TW, Wharton JT. Aborted exenterative procedures in recurrent cervical cancer. Gynecol Oncol. 1993 Jul; 50(1):94-9. PMID: 8349169.
      Citations: 6     Fields:    Translation:Humans
    131. Matthews CM, Burke TW, Tornos C, Eifel PJ, Atkinson EN, Stringer CA, Morris M, Silva EG. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. Gynecol Oncol. 1993 Apr; 49(1):19-23. PMID: 8482554.
      Citations: 4     Fields:    Translation:Humans
    132. Gershenson DM, Mitchell MF, Atkinson N, Silva EG, Burke TW, Morris M, Kavanagh JJ, Warner D, Wharton JT. Age contrasts in patients with advanced epithelial ovarian cancer. The M.D. Anderson Cancer Center experience. Cancer. 1993 Jan 15; 71(2 Suppl):638-43. PMID: 8420688.
      Citations: 7     Fields:    Translation:Humans
    133. Morris M, Gershenson DM, Eifel P, Silva EG, Mitchell MF, Burke TW, Wharton JT. Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol. 1992 Oct; 47(1):62-5. PMID: 1330847.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    134. Gershenson DM, Mitchell MF, Atkinson N, Silva EG, Kavanagh JJ, Morris M, Burke TW, Warner D, Wharton JT. The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: "maintenance" therapy reconsidered. Gynecol Oncol. 1992 Oct; 47(1):7-13. PMID: 1427404.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    135. Levenback C, Burke TW, Silva E, Morris M, Gershenson DM, Kavanagh JJ, Wharton JT. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecol Oncol. 1992 Sep; 46(3):317-21. PMID: 1526508.
      Citations: 17     Fields:    Translation:Humans
    136. Tornos C, Silva EG, el-Naggar A, Burke TW. Aggressive stage I grade 1 endometrial carcinoma. Cancer. 1992 Aug 15; 70(4):790-8. PMID: 1643610.
      Citations: 5     Fields:    Translation:Humans
    137. Matthews CM, Morris M, Burke TW, Gershenson DM, Wharton JT, Rutledge FN. Pelvic exenteration in the elderly patient. Obstet Gynecol. 1992 May; 79(5 ( Pt 1)):773-7. PMID: 1565364.
      Citations: 8     Fields:    Translation:Humans
    138. Roman LD, Morris M, Eifel PJ, Burke TW, Gershenson DM, Wharton JT. Reasons for inappropriate simple hysterectomy in the presence of invasive cancer of the cervix. Obstet Gynecol. 1992 Apr; 79(4):485-9. PMID: 1553163.
      Citations:    Fields:    Translation:Humans
    139. Kelley JL, Burke TW, Tornos C, Morris M, Gershenson DM, Silva EG, Wharton JT. Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy. Gynecol Oncol. 1992 Mar; 44(3):240-4. PMID: 1541436.
      Citations: 3     Fields:    Translation:Humans
    140. Burke TW. Changing surgical approaches to vulvar cancer. Curr Opin Obstet Gynecol. 1992 Feb; 4(1):86-90. PMID: 1543835.
      Citations:    Fields:    Translation:Humans
    141. Burke TW. Factors affecting recurrence and survival in stage I carcinoma of the uterine cervix. Oncology (Williston Park). 1992 Feb; 6(2):111-6; discussion 118-9; 122. PMID: 1532496.
      Citations: 1     Fields:    Translation:Humans
    142. Rosenblum MG, Kavanagh JJ, Burke TW, Wharton JT, Cunningham JE, Shanken LJ, Silva EG, Thompson L, Cheung L, Lamki L, et al. Clinical pharmacology, metabolism, and tissue distribution of 90Y-labeled monoclonal antibody B72.3 after intraperitoneal administration. J Natl Cancer Inst. 1991 Nov 20; 83(22):1629-36. PMID: 1721093.
      Citations: 5     Fields:    Translation:Humans
    143. Morris M, Gershenson DM, Burke TW, Wharton JT, Copeland LJ, Rutledge FN. Splenectomy in gynecologic oncology: indications, complications, and technique. Gynecol Oncol. 1991 Nov; 43(2):118-22. PMID: 1743552.
      Citations: 4     Fields:    Translation:Humans
    144. Jacob JH, Gershenson DM, Morris M, Copeland LJ, Burke TW, Wharton JT. Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer. Gynecol Oncol. 1991 Aug; 42(2):146-50. PMID: 1894174.
      Citations: 14     Fields:    Translation:Humans
    145. Eifel PJ, Burke TW, Delclos L, Wharton JT, Oswald MJ. Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameter. Gynecol Oncol. 1991 Jun; 41(3):199-205. PMID: 1869095.
      Citations: 8     Fields:    Translation:Humans
    146. Roman LD, Mitchell MF, Burke TW, Silva EG. Unsuspected invasive squamous cell carcinoma of the vulva in young women. Gynecol Oncol. 1991 May; 41(2):182-5. PMID: 2050311.
      Citations: 1     Fields:    Translation:Humans
    147. Burke TW, Stringer CA, Morris M, Freedman RS, Gershenson DM, Kavanagh JJ, Edwards CL. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Gynecol Oncol. 1991 Mar; 40(3):264-7. PMID: 2013451.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    148. Smiley LM, Burke TW, Silva EG, Morris M, Gershenson DM, Wharton JT. Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence. Obstet Gynecol. 1991 Feb; 77(2):271-5. PMID: 1988891.
      Citations: 8     Fields:    Translation:Humans
    149. Kline RC, Wharton JT, Atkinson EN, Burke TW, Gershenson DM, Edwards CL. Endometrioid carcinoma of the ovary: retrospective review of 145 cases. Gynecol Oncol. 1990 Dec; 39(3):337-46. PMID: 2258081.
      Citations: 8     Fields:    Translation:Humans
    150. Morris M, Gershenson DM, Burke TW, Kavanagh JJ, Silva EG, Wharton JT. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol. 1990 Dec; 76(6):1020-4. PMID: 2234710.
      Citations: 7     Fields:    Translation:Humans
    151. Burke TW, Stringer CA, Gershenson DM, Edwards CL, Morris M, Wharton JT. Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva. Gynecol Oncol. 1990 Sep; 38(3):328-32. PMID: 2227543.
      Citations: 5     Fields:    Translation:Humans
    152. Stringer CA, Gershenson DM, Burke TW, Edwards CL, Gordon AN, Wharton JT. Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: a preliminary analysis. Gynecol Oncol. 1990 Sep; 38(3):305-8. PMID: 2227540.
      Citations: 3     Fields:    Translation:Humans
    153. Rellihan MA, Dooley DP, Burke TW, Berkland ME, Longfield RN. Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol Oncol. 1990 Mar; 36(3):435-8. PMID: 2318457.
      Citations: 12     Fields:    Translation:Humans
    154. Lee RB, Burke TW, Park RC. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol. 1990 Feb; 36(2):189-91. PMID: 2298408.
      Citations: 16     Fields:    Translation:Humans
    155. Burke TW, Heller PB, Woodward JE, Davidson SA, Hoskins WJ, Park RC. Treatment failure in endometrial carcinoma. Obstet Gynecol. 1990 Jan; 75(1):96-101. PMID: 2296431.
      Citations: 5     Fields:    Translation:Humans
    156. Doering DL, Barnhill DR, Weiser EB, Burke TW, Woodward JE, Park RC. Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma. Obstet Gynecol. 1989 Dec; 74(6):930-3. PMID: 2586959.
      Citations: 6     Fields:    Translation:Humans
    157. Styron SL, Burke TW, Linville WK. Low-grade endometrial stromal sarcoma recurring over three decades. Gynecol Oncol. 1989 Nov; 35(2):275-8. PMID: 2807024.
      Citations: 3     Fields:    Translation:Humans
    158. Collins HS, Burke TW, Woodward JE, Spurlock JW, Heller PB. Widespread lymph node metastases in a patient with microinvasive cervical carcinoma. Gynecol Oncol. 1989 Aug; 34(2):219-21. PMID: 2753428.
      Citations: 3     Fields:    Translation:HumansCells
    159. Taylor SW, Barnhill DR, Burke TW, Linville WK, Yevich I. Methotrexate-induced erythema multiforme. Gynecol Oncol. 1989 Jun; 33(3):376-8. PMID: 2722066.
      Citations:    Fields:    Translation:Humans
    160. Collins HS, Burke TW, Heller PB, Olson TA, Woodward JE, Park RC. Endodermal sinus tumor of the infant vagina treated exclusively by chemotherapy. Obstet Gynecol. 1989 Mar; 73(3 Pt 2):507-9. PMID: 2464779.
      Citations: 1     Fields:    Translation:Humans
    161. Culling RD, Deppe SA, Goglin WK, Ducey JP, Burke TW. Continuous thoracic epidural analgesia for the control of pain associated with pleural sclerosis. Gynecol Oncol. 1989 Jan; 32(1):76-8. PMID: 2909451.
      Citations:    Fields:    Translation:Humans
    162. Weiser EB, Burke TW, Heller PB, Woodward J, Hoskins WJ, Park RC. Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR). Gynecol Oncol. 1988 Jun; 30(2):201-8. PMID: 3371745.
      Citations: 1     Fields:    Translation:Humans
    163. Hunter VP, Burke TW, Crooks LA. Retroperitoneal nerve sheath tumors: an unusual cause of pelvic mass. Obstet Gynecol. 1988 Jun; 71(6 Pt 2):1050-2. PMID: 3374919.
      Citations: 4     Fields:    Translation:Humans
    164. Barnhill DR, Boling R, Nobles W, Crooks L, Burke T. Vulvar dermatofibrosarcoma protuberans. Gynecol Oncol. 1988 May; 30(1):149-52. PMID: 3366391.
      Citations: 2     Fields:    Translation:Humans
    165. Nash JD, Burke TW, Woodward JE, Hall KL, Weiser EB, Heller PB. Diagnosis of recurrent gynecologic malignancy with fine-needle aspiration cytology. Obstet Gynecol. 1988 Mar; 71(3 Pt 1):333-7. PMID: 3347417.
      Citations: 2     Fields:    Translation:Humans
    166. Burke TW, Heller PB, Hoskins WJ, Weiser EB, Nash JD, Park RC. Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma. Gynecol Oncol. 1987 Nov; 28(3):312-7. PMID: 3678980.
      Citations:    Fields:    Translation:Humans
    167. Barnhill D, Hoskins W, Burke T, Weiser E, Heller P, Park R. The treatment of retroperitoneal fibromatosis with medroxyprogesterone acetate. Obstet Gynecol. 1987 Sep; 70(3 Pt 2):502-4. PMID: 2957621.
      Citations:    Fields:    Translation:Humans
    168. Gschwend J, Burke TW, Woodward JE, Heller PB. Retroperitoneal teratoma presenting as an abdominal-pelvic mass. Obstet Gynecol. 1987 Sep; 70(3 Pt 2):500-2. PMID: 3627612.
      Citations: 13     Fields:    Translation:Humans
    169. Spurlock JW, Burke TW, Dunn NP, Heller PB, Collins HS, Park RC. Calyceal rupture with perirenal urinoma in a patient with cervical carcinoma. Obstet Gynecol. 1987 Sep; 70(3 Pt 2):511-3. PMID: 3627616.
      Citations: 4     Fields:    Translation:Humans
    170. Burke TW, Hoskins WJ, Heller PB, Shen MC, Weiser EB, Park RC. Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma. Obstet Gynecol. 1987 Mar; 69(3 Pt 1):382-5. PMID: 3822285.
      Citations: 9     Fields:    Translation:Humans
    171. Hoskins WJ, Burke TW, Weiser EB, Heller PB, Grayson J, Park RC. Right hemicolectomy and ileal resection with primary reanastomosis for irradiation injury of the terminal ileum. Gynecol Oncol. 1987 Feb; 26(2):215-24. PMID: 3804037.
      Citations:    Fields:    Translation:HumansPHPublic Health
    172. Nash JD, Burke TW, Hoskins WJ. Biologic course of cervical human papillomavirus infection. Obstet Gynecol. 1987 Feb; 69(2):160-2. PMID: 3027635.
      Citations: 13     Fields:    Translation:HumansCells
    173. Burke TW, Weiser EB, Hoskins WJ, Heller PB, Nash JD, Park RC. End colostomy using the end-to-end anastomosis instrument. Obstet Gynecol. 1987 Feb; 69(2):156-9. PMID: 3808502.
      Citations:    Fields:    Translation:Humans
    174. Burke TW, Hoskins WJ, Heller PB, Bibro MC, Weiser EB, Park RC. Prognostic factors associated with radical hysterectomy failure. Gynecol Oncol. 1987 Feb; 26(2):153-9. PMID: 3804033.
      Citations: 3     Fields:    Translation:Humans
    175. Foreword. Gynecologic Oncology. 112.
    176. Radiotherapy for recurrent small cell carcinoma of the ovary. Gynecologic Oncology Case Reports. 11:23-25.
    177. Primary treatment failure in patients with malignant ovarian germ cell neoplasms. International Journal of Gynecological Cancer. 2:295-300.
    178. Endometrial cancer. 109-117.
    179. Intraoperative lymphatic mapping for vulvar cancer. ACOG Current Journal Review. 8:41.
    180. Prognostic factors associated with radical hysterectomy failure. Obstetrical and Gynecological Survey. 42:585-587.
    181. Gynecologic malignancies in pregnancy. Cancer Bulletin. 46:424-431.
    182. Clinical and pathological risk factors in stage I cervical cancer. Clinical Consultations in Obstetrics and Gynecology. 7:118-125.
    183. Small bowel procedures. Operative Techniques in Gynecologic Surgery. 6:64-69.
    184. Advanced-Stage Vulvar Cancer. 105-112.
    185. Treatment options in stage IB cervical cancer. Seminars in Radiation Oncology. 4:34-40.
    186. Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide for early-stage high-risk endometrial cancer. Obstetrical and Gynecological Survey. 46:168-169.
    187. 60 Years of survival outcomes at the university of Texas MD Anderson cancer center.
    188. Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva. Obstetrical and Gynecological Survey. 46:166-167.
    189. Identification of primary chromosome abnormalities in a patient with endometrial carcinoma. International Journal of Oncology. 7:765-772.
    190. 3 lessons from this year's quest for quality applicants. Hospitals and Health Networks. 90.
    191. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Obstetrical and Gynecological Survey. 45:558-559.
    BURKE's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (533)
    Explore
    _
    Co-Authors (52)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _